(Q48491694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

10

Michael Flentje

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Dirk Vordermark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jörn Wulf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Klaus Markert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kurt Baier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Oliver Kölbl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gabriele Beckmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael Noe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Georg Schön

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

708-716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16938814%20AND%20SRC:MED&resulttype=core&format=json

Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

The zonal anatomy of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

A systematic overview of radiation therapy effects in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Planning target volume definition in dose-escalation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Prostate cancer radiotherapy dose response: an update of the fox chase experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: a prospective assessment of acute and late treatment toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913

High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860600710913